Supervisory Board

Mark Iwicki (Chairman)

Mark Iwicki has been a member of the Board since June 2015.

Gregory Perry

Gregory Perry has been a member of our supervisory board since May 2016. Mr. Perry has been the chief financial and administrative officer of Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, since July 2015. Prior to joining Aegerion Pharmaceuticals, Mr. Perry served as chief financial and business officer of Eleven Biotherapeutics, Inc., a biopharmaceutical company, from […]

Lionel Carnot

Lionel Carnot, MS, MBA, has been a member of the Board since January 2010.

Wolf Berthold, Ph.D.

Wolf Berthold, Ph.D., has been a member of the Board since 2010. Wolf is the president of Berthold BioPharm Consulting GmbH.

John de Koning, Ph.D.

John de Koning, Ph.D., has been a member of Merus´ Board since January 2010. John is a partner at Life Sciences Partners (LSP).

Anand Mehra, M.D.

Anand Mehra, M.D. was nominated to serve on the supervisory board by Sofinnova Venture Partners IX, L.P., one of our shareholders, and has been a member of the supervisory board since August 2015. Dr. Mehra has been with Sofinnova Ventures since 2007, most recently holding the position of a general partner where he focuses on […]

Jack B. Nielsen

Jack B. Nielsen was nominated to serve on the supervisory board by Novo A/S, one of our shareholders, and has been a member of the supervisory board since August 2015. Mr. Nielsen has worked within Novo A/S and its venture activities since 2001 in several roles. Novo A/S is a Denmark limited liability company that […]

Anne Noordzij, LL.M. (Secretary)

Anne Noordzij holds a law degree and has been Head of Legal and secretary to the Supervisory Board since November 2015. Before joining Merus, Anne was a lawyer at one of the top Dutch law firms in the Netherlands, NautaDutilh N.V., where she advised in a variety of transactions, with a focus on the Life […]